Treatment combining CD200 immune checkpoint inhibitor and tumor-lysate vaccination after surgery for pet dogs with high-grade glioma MR Olin, E Ampudia-Mesias, CA Pennell, A Sarver, CC Chen, CL Moertel, ... Cancers 11 (2), 137, 2019 | 36 | 2019 |
Cd200 checkpoint reversal: a novel approach to immunotherapy Z Xiong, EA Mesias, GE Pluhar, SK Rathe, DA Largaespada, YY Sham, ... Clinical Cancer Research 26 (1), 232-241, 2020 | 31 | 2020 |
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy Z Xiong, E Ampudia-Mesias, R Shaver, CM Horbinski, CL Moertel, ... Immunotherapy 8 (9), 1059-1071, 2016 | 27 | 2016 |
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway E Ampudia-Mesias, F Puerta-Martinez, M Bridges, D Zellmer, A Janeiro, ... Neurotherapeutics, 1-15, 2021 | 7 | 2021 |
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway GEPMRO Elisabet Ampudia-Mesias, Francisco Puerta-Martinez, Miurel Bridges ... Neurotherapeutics, 2021 | 7 | 2021 |
Use of CD200 blockade inhibitor to enhance glioma immunotherapy E Mesias, Z Xiong, E Pluhar, M Olin Journal for ImmunoTherapy of Cancer 3 (2), 1-1, 2015 | 4 | 2015 |
CD200 immune checkpoint reversal at the site of tumor vaccine inoculation: A novel approach to glioblastoma immunotherapy Z Xiong, E Ampudia-Mesias, GE Pluhar, SK Rathe, DA Largaespada, ... BioRxiv, 726778, 2019 | 1 | 2019 |
IMMU-11. Targeting the CD200 checkpoint blockade: a new direction for immunotherapy M Olin, E Ampudia-Mesias, Z Xiong, E Pluhar, C Moertel Neuro-oncology 19 (Suppl 6), vi114, 2017 | 1 | 2017 |
IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY E Ampudia-Mesias, C Moertel, M Olin Neuro-Oncology 19 (Suppl 4), iv27, 2017 | 1 | 2017 |
Unraveling the Signaling Pathways of the CD200 Activation Receptor Family and Their Implications in Regulating Antitumor Response in Glioblastoma EA Mesias University of Minnesota, 2020 | | 2020 |
Unraveling the Signaling Pathways of the Cd200 Activation Receptor Family and Their Implications in Regulating Antitumor Response in Glioblastoma E Ampudia Mesias | | 2020 |
CD200 Inhibition Enhanced the Anti-glioblastoma Effects of Autologous Tumor Vaccination for In Vivo Murine and Canine Glioblastoma models T Do, M Olin, E Ampudia-Mesias, C Pennell, Z Xiong, S Rathe, ... JOURNAL OF NEUROSURGERY 131 (1), 2019 | | 2019 |
TARGETING THE CD200 CHECKPOINT TO ENHANCE IMMUNOTHERAPY FOR CNS TUMORS: IMMU-23. C Moertel, E Pluhar, E Ampudia-Mesias, Z Xiong, C Pennell, S Rathe, ... Neuro-oncology 21, 2019 | | 2019 |
IMMU-23. TARGETING THE CD200 CHECKPOINT TO ENHANCE IMMUNOTHERAPY FOR CNS TUMORS C Moertel, GE Pluhar, E Ampudia-Mesias, Z Xiong, CA Pennell, SK Rathe, ... Neuro-Oncology 21 (Suppl 2), ii97, 2019 | | 2019 |
CADD-14. TARGETING THE CD200 CHECKPOINT FOR THE FIGHT AGAINST CENTRAL NERVOUS SYSTEM TUMORS M Olin, E Ampudia-Mesias, CA Pennell, Z Xiong, SK Rathe, ... Neuro-Oncology 20 (Suppl 6), vi278, 2018 | | 2018 |
IMMU-03. TARGETING THE CD200 CHECKPOINT BLOCKADE FOR THE FIGHT AGAINST CENTRAL NERVOUS SYSTEM TUMORS E Pluhar, E Ampudia-Mesias, Z Xiong, C Moertel, M Olin Neuro-oncology 20 (Suppl 2), i99, 2018 | | 2018 |
IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT E Ampudia-Mesias, C Moertel, E Pluhar, M Olin Neuro-oncology 19 (Suppl 6), vi115, 2017 | | 2017 |
Effect of waterlogging on the alcohol dehydrogenase activity in yellow passion fruit roots Passiflora Edulis var. Flavicarpa KN Giraldo Cervantes, E Ampudia Mesias, M Bravo, J Restrepo Osorio Revista Colombiana de Biotecnología 17 (2), 114-122, 2015 | | 2015 |
Efecto del anegamiento en la actividad de la enzima alcohol deshidrogenasa en raíces de maracuyá amarillo Passiflora Edulis var. Flavicarpa KNG Cervantes, E Ampudia-Mesias, EB Montaño, JR Osorio Revista colombiana de biotecnología 17 (2), 114-122, 2015 | | 2015 |